Facebook Twitter YouTube Google Plus

R.) The Use of Cytokine Inhibitors: Translational Lab Results

Sheelu Varghese, PhD
University of Maryland

Dr. Sheelu Varghese obtained a Ph.D in Molecular Endocrinology and Biochemistry from the Department of Zoology, University of Kerala, India. He attained a strong interest in cancer research early in his 5 years postdoctoral training at the National Cancer Institute (NCI), USA where he joined the laboratory of H. Richard Alexander, M.D., in the Surgery Branch. Since then he has focused his research on tumor biology and metastatic tumor growth. Dr. Varghese led the laboratory research efforts in the genetic and proteomic analyses of fresh patient tumors to identify novel targets for therapeutic intervention. His research was focused on malignant peritoneal mesothelioma and on the metastatic spread of colorectal cancer and ocular melanoma. In an attempt to generate model systems for peritoneal mesothelioma research, he has generated several peritoneal mesothelioma cell lines and tumor models. In 2006 Dr. Varghese joined in the Department of Surgery University of Maryland School of Medicine (UMSOM) as a junior faculty research scientist.  He has a strong interest in basic tumor biology to understand the mechanisms of tumor progression to develop new translational approaches for the treatment of various cancers.

Click here to view the slides for "The Use of Cytokine Inhibitors: Translational Lab Results", by Sheelu Varghese, PhD.

To view this video presentation, please click on the image below.

© 2009 Mesothelioma Applied Research Foundation, Inc. All rights reserved. 501(c)(3)

A.) Effective Advocacy and the Case for Federal Meso Research Funding

B.) State Assistance on Insurance Appeals

C.) Cancer Genetics in the Mesothelioma Family

D.) Fundraising

E.) Navigating Mesothelioma Clinical Trials with GPS (Getting Personalized Service)

F.) Update from Across the Pond

G.) The Mesothelioma Experience: Patient and Provider Perspectives Panel

H.) Work of the Science Advisory Board

J.) Present and Future of Mesothelioma Treatment: Medical Oncologist and Researcher Perspective

K.) New Developments in Radiation Oncology: A Global Perspective

M.) Pain Management

Mesothelioma Treatment: Present & Future from a Surgeon & Research Perspective | Dr. Harvey Pass

N.) Traditional Healing with Modern Science

O.) Update on Clinical Trials and Mesothelioma Research

P.) Mesothelioma Tissue Bank

Photodynamic Therapy for Mesothelioma Treatment | Dr. Joseph Friedberg

Q.) EGFR Inhibitors for Patients with Malignant Peritoneal Mesothelioma

R.) The Use of Cytokine Inhibitors: Translational Lab Results

S.) Identifying and Targeting Aggressive Malignant Peritoneal Mesothelioma: Morphologic and Molecular Studies

T.) Treatment Options for Patients with Recurrent Disease after HIPEC, HRA - Panel Discussion